On ECHEMI
Home > Drugs > Nintedanib esylate Registered Holders
Nintedanib esylate structure

Nintedanib esylate structure

Nintedanib esylate

Nintedanib esylate (BIBF 1120 esylate) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.

Find 35 Related Holders

HUBEI CHENGTIAN PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
SHANDONG ANHONG PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
Guangzhou Tosun Pharmaceutical Ltd
China China

API Registration Country

API Inactive
  • Founded in:

    1999-12-28
  • Country:

    China China
  • Address:

    Room 1203, Room 1201, 181 Science Avenue, Huangpu District, Guangzhou (Office Only)
  • Tax NO.:

    91440105718174018Y
  • Registered Funds:

    10 million yuan
  • Website:

  • Email:

Jiangxi Guoyao Pharmaceutical Limited Liability Company
China China

API Registration Country

API Inactive
  • Founded in:

    1990-03-24
  • Country:

    China China
  • Address:

    No. 388, Hebo Road, Xiaolan Economic and Technological Development Zone, Nanchang County, Nanchang City, Jiangxi Province
  • Tax NO.:

    91360000158261876R
  • Registered Funds:

    183.60191 million yuan
  • Email:

Wuxi JIDA Pharmaceutical Co., Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    2003-11-21
  • Country:

    China China
  • Address:

    No. 11, Nanqiu Road, Chengchang Industrial Park, Huangtu Town, Jiangyin City
  • Tax NO.:

    913202817564102027
  • Registered Funds:

    73 million yuan
  • Website:

  • Email:

Recommended Suppliers of Nintedanib esylate
View 41 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.